Search Results - "Pinturaud, Marine"

Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study by Simon, Nicolas, Vasseur, Michèle, Pinturaud, Marine, Soichot, Marion, Richeval, Camille, Humbert, Luc, Lebecque, Michèle, Sidikou, Ousseini, Barthelemy, Christine, Bonnabry, Pascal, Allorge, Delphine, Décaudin, Bertrand, Odou, Pascal

“…The objective of this randomized, prospective and controlled study was to investigate the ability of a closed-system transfer device (CSTD; BD-Phaseal) to…”
Get full text

Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit by Petit, Ophélie, Saint-Lorant, Guillaume, Vasseur, Michèle, Boucher, Julie, Courtin, Justin, Pinturaud, Marine, Allorge, Delphine, Decaudin, Bertrand, Simon, Nicolas, Odou, Pascal

“…An important amount of cytotoxic drug may accumulate in the workplace following the breakage of a vial containing an anticancer drug. Thanks to the monthly…”
Get full text

Assessment of chemical contamination by cancer drugs during use of the RIVATM compounding robot: A pilot study by Bouchfaa, Myriam, Vasseur, Michèle, Courtin, Justin, Pinturaud, Marine, Beauval, Nicolas, Allorge, Delphine, Odou, Pascal, Simon, Nicolas

“…Many hospitals are now investing in robotic compounding system for the preparation of cytotoxic agents. The objective of the present study was to describe…”
Get full text

Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study by Bouchfaa, Myriam, Vasseur, Michèle, Courtin, Justin, Pinturaud, Marine, Beauval, Nicolas, Allorge, Delphine, Odou, Pascal, Simon, Nicolas

“…Many hospitals are now investing in robotic compounding system for the preparation of cytotoxic agents. The objective of the present study was to describe…”
Get full text

A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off by Leroy, Marie, Deramoudt, Laure, Pinturaud, Marine, Demaret, Julie, Alidjinou, Enagnon Kazali, Nudel, Morgane, Cavalieri, Doriane, Chahla, Wadih Abou, Odou, Pascal, Morschhauser, Franck, Yakoub-Agha, Ibrahim, Simon, Nicolas, Beauvais, David

Get full text

Requirements for academic production of CAR-T cells in accordance with Good Pharmaceutical Practice (GMP). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) by Deschamps, Marina, Decot, Véronique, Giverne, Camille, Pinturaud, Marine, Vaissié, Alix, Parquet, Nathalie, Olivero, Sylvain, Anne-Claire, Mamez, Bay, Jacques-Olivier, Yakoub-Agha, Ibrahim, Ferrand, Christophe

“…The extraordinary and unexpected success of cellular immunotherapy using genetically engineered T-cells to express a chimeric antigen receptor (CAR) targeting…”
Get more information

Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) by Yakoub-Agha, Ibrahim, Ferrand, Christophe, Chalandon, Yves, Ballot, Caroline, Castilla Llorente, Cristina, Deschamps, Marina, Gauthier, Jordan, Labalette, Myriam, Larghero, Jérôme, Maheux, Camille, Moreau, Anne-Sophie, Varlet, Pauline, Pétillon, Marie-Odile, Pinturaud, Marine, Rubio, Marie Thérèse, Chabannon, Christian

“…CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen…”
Get more information

Rôle du pharmacien hospitalier dans le circuit d’une catégorie de Médicament de Thérapie Innovante : les lymphocytes T exprimant un Récepteur Chimérique à l’Antigène by Pinturaud, Marine, Vasseur, Michèle, Odou, Pascal

“…Les lymphocytes T exprimant un Récepteur Chimérique à l’Antigène (CART) appartiennent à une nouvelle classe de médicaments, les médicaments de thérapies…”
Get full text

In Vitro Assessment of a New Extension Set Intended to Reduce Occupational Exposure to Antineoplastic Drugs During Hepatic Chemoembolisation by Sidikou, O., Simon, N., Sergent, G., Vasseur, M., Pinturaud, M., Richeval, C., Allorge, D., Décaudin, B., Odou, P.

Get full text

Prérequis pour une production académique des cellules CART conforme aux bonnes pratiques pharmaceutiques (BPF). Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) by Deschamps, Marina, Decot, Véronique, Giverne, Camille, Pinturaud, Marine, Vaissié, Alix, Parquet, Nathalie, Olivero, Sylvain, Anne-Claire, Mamez, Bay, Jacques-Olivier, Yakoub-Agha, Ibrahim, Ferrand, Christophe

“…Le succès aussi extraordinaire qu’inattendu de l’immunothérapie cellulaire utilisant des lymphocytes T génétiquement modifiés pour exprimer un récepteur…”
Get full text

Prérequis nécessaires pour la mise en place de protocoles de recherche clinique évaluant des thérapies cellulaires et géniques par lymphocytes T dotés de récepteur chimérique à l’antigène (CAR T-cells) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) by Yakoub-Agha, Ibrahim, Ferrand, Christophe, Chalandon, Yves, Ballot, Caroline, Castilla Llorente, Cristina, Deschamps, Marina, Gauthier, Jordan, Labalette, Myriam, Larghero, Jérôme, Maheux, Camille, Moreau, Anne-Sophie, Varlet, Pauline, Pétillon, Marie-Odile, Pinturaud, Marine, Rubio, Marie Thérèse, Chabannon, Christian

“…Les cellules T – autologues ou allogéniques – génétiquement manipulées pour exprimer un récepteur antigénique chimérique (« CAR T-cells ») et reconnaître un…”
Get full text

Accidental poisoning with transdermal fentanyl patch in a 8 months old infant by Pinturaud, Marine, Pruvost, Isabelle, Leteurtre, Stéphane, Martinot, Alain, Gautier, Sophie

Get more information